Frank Buettner, Attenweiler DE
Frank Buettner, Attenweiler DE
Patent application number | Description | Published |
---|---|---|
20080241817 | Detection of NO By Using Guanylyl Cyclase and cGMP Production as a Readout System - The present invention relates to a method for determining NO enzymatically and its use for the identification of substances which can modulate a nitric oxide synthase activity. | 10-02-2008 |
20090029990 | Dihydropteridinones in the treatment of respiratory diseases - The present invention relates to the use of dihydropteridinones of formula 1 | 01-29-2009 |
20090092558 | MEDICAMENTS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A pharmaceutical composition comprising a compound of formula 1 | 04-09-2009 |
20090156554 | P13-KINASES - New compounds of formula 1 are provided which by virtue of their pharmaceutical activity as PI3-kinase modulators may be used in the therapeutic field for the treatment of inflammatory or allergic diseases. | 06-18-2009 |
20090280115 | Dihydropteridinones in the Treatment of Respiratory Diseases - The present invention relates to the use of dihydropteridinones of formula 1 | 11-12-2009 |
20100248282 | DETECTION OF NO BY USING GUANYLYL CYCLASE AND cGMP PRODUCTION AS A READOUT SYSTEM - The present invention relates to a method for determining NO enzymatically and its use for the identification of substances which can modulate a nitric oxide synthase activity. | 09-30-2010 |
20130172323 | PYRIDAZINONES AS GPR119 AGONISTS - The present invention relates to pyridazinone derivatives of general formula I, wherein the groups A, G and R | 07-04-2013 |
20130324517 | CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD - The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD. | 12-05-2013 |